what is going on with semaglutide Do Side Effects Go Away? Understanding Your Journey Semaglutide – PlexusDx Semaglutide: The benefits and risks

GLP2: an underestimated signal for improving glycaemic control and insulin sensitivity

This blog will explain: What Are GLP-1 Drugs, Anyway

But three honest qualifications collapse the confident version of the claim

Exploratory analyses suggested that the elevated dementia risk associated with diet soda was strongest in nonHispanic white and Black participants

Research on GLP-1 medications shows that approximately 40% of patients report increased sensitivity to acidic or heavily seasoned foods during the first 812 weeks of therapy

Polycystic Ovary Syndrome (PCOS) - 5-10% of women 50% lower glutathione levels compared to women without PCOS 3-4x higher risk of preeclampsia 3x higher risk of gestational diabetes Critical concern: With 50% lower baseline glutathione, the "safe" dose is effectively cut in half IVF Conception - 2-5% of births (up to 6-8% in some countries) Women who conceive via IVF experience dramatic antioxidant depletion: 70% reduction in plasma antioxidant capacity 83% reduction in follicular fluid antioxidant capacity 50-100%+ increase in oxidative stress markers With over 5 million babies born via IVF globally, this represents a large high-risk population Gallbladder Dysfunction - 10% of pregnant women Up to 10% develop gallstones or biliary sludge Intrahepatic cholestasis: 0.4-10% of pregnancies CRITICAL: Fatal Outcomes Documented at Therapeutic Doses The first case of a pregnant woman with intrahepatic cholestasis who died from liver failure after taking THERAPEUTIC/NORMAL doses of acetaminophen was reported in 2022